A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

NCT00454636 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Cisplatin
DRUG: Capecitabine
DRUG: Epirubicin
DRUG: Cisplatin
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Docetaxel
DRUG: Capecitabine

Sponsor

Hoffmann-La Roche